Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uriexo Attack+
- Development stage
- Unknown
- Lead developer
- Tyros Biopharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
URIEXO Attack+ is an over-the-counter natural health product formulated to support urinary tract health and prevent recurrent urinary tract infections (UTIs) and cystitis. Developed by Tyros Biopharma, each daily dose delivers a combination of clinical-strength D-mannose (2000 mg) and vitamin C (75 mg). D-mannose serves as a competitive inhibitor that binds to the FimH adhesin on the type 1 fimbriae of uropathogenic Escherichia coli (UPEC), preventing the bacteria from adhering to the urothelium and allowing them to be flushed out during urination. Vitamin C provides antioxidant protection, supports immune function, and helps acidify the urine, creating an environment less favorable to bacterial proliferation. This non-antibiotic approach offers a proactive defense against recurrent UTIs without contributing to antibiotic resistance.
- Brand names
- Uriexo Attack+
- Other names
- D-mannose + ascorbic acidD-mannose + vitamin C
02
Targets
FimH (Type 1 fimbrial adhesin)
Beyond the preview
Go deeper on Uriexo Attack+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Uriexo Attack+.